Intec Pharma Ltd (NTEC):製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C7953)
◆英語タイトル:Intec Pharma Ltd (NTEC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7953
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:47
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Intec Pharma Ltd (Intec Pharma) is a biopharmaceutical company that offers delivery solutions for drugs. The company’s pipeline products include drug indications for Parkinson’s disease, insomnia and other diseases. Its proprietary gastro retentive formulation, offers a drug delivery solution to drugs that have poor solubility, poor colonic absorption or act locally in upper gastrointestinal part. Intec Pharma offers products for various therapeutic areas including the central nervous system, the cardiovascular system, and gastrointestinal and infectious diseases. It has collaborations with pharmaceutical and biopharmaceutical companies. Intec Pharma is headquartered in Jerusalem, Israel.

Intec Pharma Ltd (NTEC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Intec Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Intec Pharma Enters into Agreement with LTS Lohmann Therapie 10
Intec Pharma Enters into Research Agreement with Biogen MA 11
Licensing Agreements 13
Intec Pharma Enters into Agreement with Novartis Pharma 13
Intec Pharma Enters into Licensing Agreement with a Pharma Company 14
Equity Offering 15
Intec Pharma Raises USD35.4 Million in Public Offering of Shares 15
Intec Pharma Raises USD57.5 Million in Public Offering of Shares 17
Intec Pharma Raises USD10 Million in Private Placement of Shares 18
Intec Pharma Completes Public Offering of Shares for USD34 Million 19
Intec Pharma Ltd – Key Competitors 21
Intec Pharma Ltd – Key Employees 22
Intec Pharma Ltd – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Financial Announcements 24
Aug 15, 2018: Intec Pharma announces second quarter 2018 financial results 24
May 15, 2018: Intec Pharma Reports First Quarter 2018 Financial Results and Corporate Update 26
Mar 09, 2018: Intec Pharma Announces Fourth Quarter and Year End 2017 Financial Results 28
Nov 15, 2017: Intec Pharma Reports Third Quarter 2017 Operating and Financial Results 31
Aug 09, 2017: Intec Pharma Reports Financial Results for the First Six Months of 2017 33
Apr 07, 2017: Intec Pharma Reports 2016 Fourth Quarter and Full Year Financial Results 35
Corporate Communications 37
Jun 29, 2018: Intec Pharma Appoints William Bradley Hayes to Board of Directors 37
Mar 26, 2018: Intec Pharma Appoints Roger J. Pomerantz, M.D. to Board of Directors 38
Nov 01, 2017: Intec Pharma Announces Changes to its Board of Directors 39
Oct 26, 2017: Intec Pharma Names Walt Linscott as Chief Administrative Officer 40
Jul 27, 2017: Intec Pharma Promotes Nadav Navon, Ph.D. to Chief Operating Officer 41
Jul 10, 2017: Intec Pharma Appoints U.S. Life Sciences Executive and Vice Chairman Jeffrey A. Meckler as Chief Executive Officer 42
May 03, 2017: Intec Pharma Announces CEO Change 43
Apr 09, 2017: Intec Pharma Appoints U.S. Life Sciences Executive Jeffrey A. Meckler to its Board of Directors as Vice Chairman 44
Clinical Trials 45
Aug 03, 2017: Intec Pharma Reports Clinical Results From Phase I Trial of Accordion Pill for Cannabinoid Therapies 45
Mar 22, 2017: Intec Pharma Initiates Phase I Trial of Accordion Pill for Cannabinoid Therapies 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Intec Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Intec Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Intec Pharma Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Intec Pharma Enters into Agreement with LTS Lohmann Therapie 10
Intec Pharma Enters into Research Agreement with Biogen MA 11
Intec Pharma Enters into Agreement with Novartis Pharma 13
Intec Pharma Enters into Licensing Agreement with a Pharma Company 14
Intec Pharma Raises USD35.4 Million in Public Offering of Shares 15
Intec Pharma Raises USD57.5 Million in Public Offering of Shares 17
Intec Pharma Raises USD10 Million in Private Placement of Shares 18
Intec Pharma Completes Public Offering of Shares for USD34 Million 19
Intec Pharma Ltd, Key Competitors 21
Intec Pharma Ltd, Key Employees 22

List of Figures
Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Intec Pharma Ltd (NTEC):製薬・医療:M&Aディール及び事業提携情報(Intec Pharma Ltd (NTEC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆